Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure
- PMID: 10618274
- PMCID: PMC95819
- DOI: 10.1128/CDLI.7.1.40-44.2000
Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure
Abstract
Three important antigenic sites involved in virus neutralization on polioviruses in mouse experiments have been identified. These sites are located at the surface of the virion and have been designated antigenic sites 1, 2, and 3. In mice, the antibody response to antigenic site 1 of serotype 3 poliovirus is considered to be immunodominant, but little is known about the immunogenicity of these sites in humans. In the present study, we developed inhibition enzyme-linked immunosorbent assays specific for antigenic sites 1 and 3 to measure antibody responses to these sites in fully vaccinated inactivated poliovirus vaccine (IPV) (n = 63) and oral live attenuated poliovirus vaccine (OPV) (n = 63) recipients and in naturally infected persons (n = 25). Similar levels of antibodies to site 1 in IPV and OPV vaccinees were detected. However, significantly more OPV recipients (88.7%) had detectable antibodies to antigenic site 3 (P < 0.01) than did IPV-vaccinated persons (63. 1%). After an IPV booster vaccination, both previously IPV- and OPV-vaccinated persons responded with a significant increase in antibodies to sites 1 and 3 (P < 0.01). We conclude that the immune response to serotype 3 poliovirus in humans consists of both site 1- and site 3-specific antibodies and that these responses can be induced by either OPV or recent IPV vaccination.
Figures


Similar articles
-
Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.J Infect Dis. 1989 Jun;159(6):1018-24. doi: 10.1093/infdis/159.6.1018. J Infect Dis. 1989. PMID: 2470831
-
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.Lancet. 1993 Jun 19;341(8860):1545-50. doi: 10.1016/0140-6736(93)90693-b. Lancet. 1993. PMID: 8099637 Clinical Trial.
-
Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.Ann N Y Acad Sci. 1995 May 31;754:97-107. doi: 10.1111/j.1749-6632.1995.tb44442.x. Ann N Y Acad Sci. 1995. PMID: 7625685
-
Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?Public Health Rev. 1993-1994;21(1-2):143-50. Public Health Rev. 1993. PMID: 8041881 Review.
-
Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis.Hum Vaccin Immunother. 2018;14(11):2636-2643. doi: 10.1080/21645515.2018.1489188. Epub 2018 Jul 16. Hum Vaccin Immunother. 2018. PMID: 29985751 Free PMC article.
Cited by
-
Role of innate lymphoid cells and dendritic cells in intradermal immunization of the enterovirus antigen.NPJ Vaccines. 2019 Mar 27;4:14. doi: 10.1038/s41541-019-0108-6. eCollection 2019. NPJ Vaccines. 2019. PMID: 30937186 Free PMC article.
-
Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?Front Public Health. 2024 Jan 8;11:1284337. doi: 10.3389/fpubh.2023.1284337. eCollection 2023. Front Public Health. 2024. PMID: 38259741 Free PMC article. Review.
-
Expression and purification of polioviral proteins in E. coli, and production of antisera as reagents for immunological assays.Protein Expr Purif. 2016 Dec;128:115-22. doi: 10.1016/j.pep.2016.08.014. Epub 2016 Aug 24. Protein Expr Purif. 2016. PMID: 27565898 Free PMC article.
-
Immune response to a conserved enteroviral epitope of the major capsid VP1 protein is associated with lower risk of cardiovascular disease.EBioMedicine. 2022 Feb;76:103835. doi: 10.1016/j.ebiom.2022.103835. Epub 2022 Jan 25. EBioMedicine. 2022. PMID: 35091341 Free PMC article.
-
Comparison of IPV to tOPV week 39 boost of primary OPV vaccination in Indian infants: an open labelled randomized controlled trial.Heliyon. 2017 Jan 9;3(1):e00223. doi: 10.1016/j.heliyon.2016.e00223. eCollection 2017 Jan. Heliyon. 2017. PMID: 28194449 Free PMC article.
References
-
- Cello J, Strannegrad O, Svennerholm B. A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses. J Gen Virol. 1996;77:2097–2108. - PubMed
-
- Conyn-Spaendonck M A E, Oostvogel P M, van Loon A M, van Wijngaarden J K, Kromhout D. Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992–1993. Am J Epidemiol. 1996;143:929–934. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources